Details of CPPsite entry with Sequence HHHHHHHHHHHHHHHHRRRRRRRRRRRRRRR |
| Primary information | |
|---|---|
| PEPTIDE SEQUENCE | HHHHHHHHHHHHHHHHRRRRRRRRRRRRRRR |
| CPPsite ID | 2138, 2139, |
| PEPTIDE NAME | H16R8, STR-H16R8 |
| CHIRALITY | L, L |
| LINEAR/CYCLIC | Linear, Linear |
| SOURCE | Synthetic, Synthetic |
| CATEGORY | Cationic, Cationic |
| SUB CELLULAR LOCALIZATION | Cytoplasm, Cytoplasm |
| N-TERMINAL MODIFICATION | Acetylation, Stearylation |
| C-TERMINAL MODIFICATION | Amidation, Amidation |
| CHEMICAL MODIFICATION | NA, NA |
| UPTAKE EFFICIENCY | NA, Higher than all but less than STRH20R8 |
| PROPOSED UPTAKE MECHANISM | Endocytosis, Endocytosis |
| INVITRO/INVIVO | In vitro, In vitro |
| CELL LINE | CHO-K1 cells, HeLa, CHO-K1 cells, HeLa |
| In VIVO MODEL | NA, NA |
| CARGO | Nucleic acid (GAPDH siRNA), Nucleic acid (GAPDH siRNA) |
| PMID | 25193363, 25193363 |
| PATENT | Unknown, Unknown |
| Tertiary Structure (Technique) | 2138 (I-TASSER), 2139 (I-TASSER), |